Related Experiment Video
Updated: Jan 25, 2026

Home-Based Monitor for Gait and Activity Analysis
Published on: August 8, 2019
Intrapartum cardiotocogram monitoring between obstetricians and computer analysis
Shoichi Magawa1, Hiroaki Tanaka1, Fumi Furuhashi1
1Department of Obstetrics and Gynecology, Mie University Faculty Medicine, Tsu, Mie, Japan.
Abstract:
Purpose: To investigate the accuracy of computer analysis and its features to be used as a fu fetal heart rate (FHR) interpretation method in clinical settings.Methods: The Trium CTG Online® was used as the computer analysis software. Twenty-six cases of intrapartum FHR tracings (total time, 6900 min) were randomly selected from third-trimester pregnancies. Three obstetricians blinded to the patients' clinical information traced the decelerations, variability, and baseline cardiotocogram (CTG) data. Three obstetrician observer individually interpreted the data and only the waveforms they interpreted were adopted. The agreement between the deceleration and baseline, variability, and level of five-tier system was estimated. Weighted kappa (κ) statistics were used to assess reliability.Results: Based on the observers and Trium's classification, κ was 0.78 and the strength of agreement level was substantial. The obstetricians and Trium mostly agreed on the variability and baseline data. However, κ of each deceleration was approximately 0.65 (0.63-0.66), with substantial strength of agreement.Conclusion: Based on the obstetricians and Trium's interpretation, the latter was found to be excellent for FHR interpretation. However, it was difficult for Trium to interpret specific waveform patterns. Therefore, clinical staff should understand these characteristics to more sensitively evaluate the fetal well-being.
Related Concept Videos
Therapeutic Drug Monitoring: Drug Analysis Methods
Self-Presentation: Self-Monitoring and Self-Handicapping
Holter Monitor: 24-Hour Monitoring
Therapeutic Drug Monitoring: Affecting Factors
Strategies of Self-Presentation III: Self-Monitoring
Therapeutic Drug Monitoring: Overview and Classification

